P.A.W. Capital’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-150,000
| Closed | -$536K | – | 20 |
|
|
2023
Q1 | $536K | Sell |
150,000
-30,000
| -17% | -$107K | 1.18% | 21 |
|
|
2022
Q4 | $513K | Sell |
180,000
-20,000
| -10% | -$57K | 1.4% | 21 |
|
|
2022
Q3 | $446K | Buy |
200,000
+25,000
| +14% | +$55.8K | 0.67% | 48 |
|
|
2022
Q2 | $436K | Buy |
175,000
+25,000
| +17% | +$62.3K | 0.63% | 51 |
|
|
2022
Q1 | $732K | Buy |
150,000
+30,000
| +25% | +$146K | 0.77% | 54 |
|
|
2021
Q4 | $1.36M | Sell |
120,000
-5,000
| -4% | -$56.5K | 1.24% | 20 |
|
|
2021
Q3 | $1.82M | Hold |
125,000
| – | – | 1.62% | 18 |
|
|
2021
Q2 | $1.46M | Sell |
125,000
-15,000
| -11% | -$175K | 1.22% | 28 |
|
|
2021
Q1 | $1.71M | Hold |
140,000
| – | – | 1.5% | 21 |
|
|
2020
Q4 | $1.75M | Buy |
+140,000
| New | +$1.75M | 1.54% | 21 |
|
|
2018
Q4 | – | Sell |
-80,000
| Closed | -$724K | – | 65 |
|
|
2018
Q3 | $724K | Buy |
80,000
+50,000
| +167% | +$453K | 0.77% | 36 |
|
|
2018
Q2 | $356K | Hold |
30,000
| – | – | 0.36% | 60 |
|
|
2018
Q1 | $422K | Buy |
+30,000
| New | +$422K | 0.51% | 57 |
|